Overview: Total Ejaculate Sperm Count TestIntroduction: The Total Ejaculate Sperm Count Test measures total sperm count in ejaculate to assess male fertility, helping guide treatments for infertility. Affecting 1 in 20 men, infertility poses diagnostic challenges due to varied causes. Following 2023 World Health Organization (WHO) guidelines, it uses microscopy for high accuracy, supporting andrology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in reproductive medicine.
Other Names: Total Sperm Count Test, Male Fertility Count Assay.
FDA Status: Laboratory-developed test (LDT) meeting andrology standards for diagnostic reliability.
Historical Milestone: Total ejaculate sperm count testing began in the 1950s with research by MacLeod, who standardized counts. Microscopy advancements improved detection, surpassing earlier visual methods.
Purpose: Measures total ejaculate sperm count to assess male fertility, guides fertility treatments, and evaluates patients with infertility, aiming to improve reproductive health.
Test Parameters: Total ejaculate sperm count
Pretest Condition: Abstinence for 2-5 days required. Collect semen. Report history of fertility issues.
Specimen: Semen (sterile container, 1-5 mL); Semen in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 1 hour
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document infertility. Include current medications or sexual history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., infertility), and sample collection risks.
Procedural Considerations: Uses microscopy to count sperm, requiring labs with skilled technicians. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications or heat may alter counts, requiring correlation.
Clinical Significance: Low count suggests infertility, guiding therapy. Early treatment might improve outcomes, while untreated cases persist. Normal count may require other tests.
Specialist Consultation: Consult a urologist or reproductive specialist for interpretation.
Additional Supporting Tests: Semen analysis, hormone levels, or genetic testing to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with improper collection.
References: WHO Guidelines, 2023; Fertility and Sterility, MacLeod J, 2022.
